A. Hedman et Dkf. Meijer, THE STEREOISOMERS QUININE AND QUINIDINE EXHIBIT A MARKED STEREOSELECTIVITY IN THE INHIBITION OF HEPATOBILIARY TRANSPORT OF CARDIAC-GLYCOSIDES, Journal of hepatology, 28(2), 1998, pp. 240-249
Background / Aims: Certain basic (cationic) drugs are known to interac
t with the hepatic transport, and renal and/or biliary clearance of ca
rdia glycosides. The mechanisms behind these interactions are not full
y understood, In the present study our was to investigate the effects
of the two diastereomers, quinidine and quinine, as well as the calciu
m antagonist verapamil, on the hepatobiliary elimination of digoxin an
d ouabain in the isolated perfused rat liver. Methods: Livers from mal
e, fasting Wistar rats were perfused by recirculation of Krebs-Hensele
it bicarbonate buffer supplemented with 1% BSA. Disposition of digoxin
or ouabain was studied at an initial perfusion medium concentration (
C-i) of 100 or 10 nmol/l for digoxin and a C-i of 30 mu mol/l for ouab
ain. The C-i of quinine, quinidine or verapamil was 50 mu mol/l. Conce
ntrations of the drugs in perfusion medium and bile were followed up t
o 2 h. Results: A marked reduction in the initial medium disappearance
rate of digoxin and ouabain by quinine was found, whereas quinidine d
id not affect the hepatic disposition of the cardiac glycosides, The s
tereoselective inhibition of digoxin and ouabain clearance by quinine,
and not by quinidine, was shown to be due to an effect on the hepatic
uptake level rather than on the metabolic conversion and/or the bilia
ry excretion steps, An allosteric type of inhibition by the basic drug
s, exerted from the inside of the cells, is inferred, The's interactio
n may occur at the sinusoidal plasma membrane on the level of multi-sp
ecific carrier proteins far cardiac glycosides and cationic drugs, as
cloned recently by various groups. Conclusions: A marked stereoselecti
ve differences was found in the effect of the stereoisomers quinidine
and quinine on the hepatic uptake of digoxin and ouabain, quinine bein
g the potent inhibitor.